Loading…
DIA Europe 2019 has ended
Back To Schedule
Wednesday, February 6 • 10:45 - 11:45
#S0901: Clinical Trials and GDPR

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Tweet Share
Component Type: Session

In recent guidance, both the European Commission and the Article 29 Committee overseeing the GDPR have suggested that consent should not be the preferred basis for processing data in clinical trials. This panel will explore why this view was reached and what its implications are for the conduct of research and relations with research participants. We will in particular look at how the ethical and legal safeguards that govern clinical research, viewed from the perspective of the privacy regulator, and how these relate to the principle of accountability under GDPR.

Chair

Brendan Barnes

Speaker

The View of the Privacy Regulator
Joao Soares da Silva, MA

Company Experience in Adapting to the New Requirements
Lee Parker, JD, LLM

What do Trial Participants and Patients Think?
Souzi Makri


Speakers
BB

Brendan Barnes

Director, Multilateral Issues and Health Policy, EFPIA
BB

Brendan Barnes

Director, Multilateral Issues and Health Policy, EFPIA
avatar for Souzi Makri

Souzi Makri

Vice-President, Cyprus League Against Rheumatism
avatar for Lee Parker

Lee Parker

Director EU+ Privacy, Biogen International Gmbh
Lee Parker is Director Data Privacy Europe and Canada at Biogen. He also acts as EU Data Protection Officer. Lee is an experienced data privacy professional and English-qualified solicitor, with numerous years of pharmaceutical industry data protection experience. He is a member of... Read More →

Wednesday February 6, 2019 10:45 - 11:45 CET
F1 Austria Center Vienna Bruno-Kreisky-Platz 1 1220 Vienna Austria
  Hot Topics/Stand Alone, Session
  • Featured Topics Clinical Development
  • Tags Session